Rallybio

NASDAQ: RLYB
Developing transformative therapies for devastating rare diseases.

Sector

Life Sciences

Category

Therapeutics

Location

Farmington, CT

Initial Investment

2020
Developing transformative therapies for devastating rare diseases.

Rallybio (NASDAQ: RLYB) is a biopharmaceutical company focused on identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders.